Stay updated on DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial
Sign up to get notified when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.

Latest updates to the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page
- Check6 days agoChange DetectedThe page now includes the disease keyword 'Multiple myeloma' and a related topics section with MedlinePlus Genetics, improving navigation to context and external resources.SummaryDifference0.2%

- Check13 days agoChange DetectedThe page shows a new 'Revision: v3.6.4' tag in the metadata, while certain related topics entries (e.g., 'Multiple myeloma' and 'MedlinePlus Genetics') and the prior revision tag ('Revision: v3.6.3') have been removed, altering how related topics are presented.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page adds the disease keyword 'Multiple myeloma' and a related topics section featuring MedlinePlus Genetics, aligning the page with disease tagging and external reference links.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2, indicating a minor update to the page's documentation.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.6.2 was added as the new revision identifier at the bottom of the page. Keywords related to multiple myeloma and related topics, including MedlinePlus Genetics, were removed from the indexing list.SummaryDifference0.2%

- Check56 days agoChange DetectedEnrollment has ended for this study, as indicated by 'No longer looking for participants'. New help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment heading was updated, and the page revision is now v3.6.0.SummaryDifference0.5%

Stay in the know with updates to DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.